DD216463A5 - Verfahren zur herstellung von als histamin h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten - Google Patents

Verfahren zur herstellung von als histamin h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten Download PDF

Info

Publication number
DD216463A5
DD216463A5 DD84265516A DD26551684A DD216463A5 DD 216463 A5 DD216463 A5 DD 216463A5 DD 84265516 A DD84265516 A DD 84265516A DD 26551684 A DD26551684 A DD 26551684A DD 216463 A5 DD216463 A5 DD 216463A5
Authority
DD
German Democratic Republic
Prior art keywords
pyridyl
general formula
compound
group
oxo
Prior art date
Application number
DD84265516A
Other languages
German (de)
English (en)
Inventor
George S Sach
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DD216463A5 publication Critical patent/DD216463A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Impact Printers (AREA)
  • Steroid Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Treating Waste Gases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DD84265516A 1983-07-23 1984-07-20 Verfahren zur herstellung von als histamin h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten DD216463A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838319874A GB8319874D0 (en) 1983-07-23 1983-07-23 Compounds

Publications (1)

Publication Number Publication Date
DD216463A5 true DD216463A5 (de) 1984-12-12

Family

ID=10546171

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84265516A DD216463A5 (de) 1983-07-23 1984-07-20 Verfahren zur herstellung von als histamin h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten

Country Status (23)

Country Link
US (1) US4665078A (fr)
EP (1) EP0134091B1 (fr)
JP (1) JPS6048986A (fr)
KR (1) KR850001194A (fr)
AT (1) ATE27818T1 (fr)
AU (1) AU3080984A (fr)
CS (1) CS244446B2 (fr)
DD (1) DD216463A5 (fr)
DE (1) DE3464249D1 (fr)
DK (1) DK359184A (fr)
ES (1) ES534452A0 (fr)
FI (1) FI842907A7 (fr)
GB (1) GB8319874D0 (fr)
GR (1) GR79961B (fr)
HU (1) HUT34745A (fr)
IL (1) IL72448A0 (fr)
JO (1) JO1326B1 (fr)
NO (1) NO842963L (fr)
NZ (1) NZ208956A (fr)
PL (1) PL248859A1 (fr)
PT (1) PT78961A (fr)
RO (1) RO89219A (fr)
ZA (1) ZA845622B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT78358B (en) * 1983-04-07 1986-05-30 Smith Kline French Lab Chemical process
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
KR100581199B1 (ko) 1998-06-19 2006-05-17 카이론 코포레이션 글리코겐 신타제 키나제 3의 억제제
US10596401B2 (en) 2016-08-11 2020-03-24 Victaulic Company Modular valve assembly
US20180193681A1 (en) 2017-01-06 2018-07-12 Globe Fire Sprinkler Corporation Control valve assembly with test, drain and adjustable pressure relief valve
MX2020010222A (es) 2018-03-29 2021-01-15 Victaulic Co Of America Ensamble de válvula de retención y control de combinación para un sistema de tuberías húmedas.
EP4031788A4 (fr) 2019-09-20 2023-10-18 Victaulic Company Ensemble clapet à bille

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
IN151188B (fr) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
PT75074B (en) * 1981-06-27 1986-02-26 Smith Kline French Lab Process for preparing certain pyrimidone derivatives and compositions containing them

Also Published As

Publication number Publication date
NO842963L (no) 1985-01-24
GB8319874D0 (en) 1983-08-24
JO1326B1 (en) 1986-11-30
NZ208956A (en) 1987-03-06
KR850001194A (ko) 1985-03-16
EP0134091B1 (fr) 1987-06-16
ES8602761A1 (es) 1985-12-01
RO89219A (fr) 1986-03-15
CS244446B2 (en) 1986-07-17
GR79961B (fr) 1984-10-31
ATE27818T1 (de) 1987-07-15
CS557184A2 (en) 1985-08-15
IL72448A0 (en) 1984-11-30
JPS6048986A (ja) 1985-03-16
FI842907L (fi) 1985-01-24
ZA845622B (en) 1985-07-31
FI842907A7 (fi) 1985-01-24
ES534452A0 (es) 1985-12-01
DK359184A (da) 1985-01-24
AU3080984A (en) 1985-01-24
DE3464249D1 (de) 1987-07-23
FI842907A0 (fi) 1984-07-19
PL248859A1 (en) 1985-07-16
DK359184D0 (da) 1984-07-20
PT78961A (en) 1984-08-01
EP0134091A1 (fr) 1985-03-13
HUT34745A (en) 1985-04-28
US4665078A (en) 1987-05-12

Similar Documents

Publication Publication Date Title
DE2027645A1 (de) Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
WO1981002575A1 (fr) Derives de (1 h) -pyridinone, leur preparation et les compositions pharmaceutiques les contenant
DD202291A5 (de) Verfahren zur herstellung von als histamin-h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2713389C2 (fr)
DE2920250C2 (fr)
DD216463A5 (de) Verfahren zur herstellung von als histamin h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2847792A1 (de) N-4-chinolyl-guanidine, verfahren zu deren herstellung und pharmazeutische mittel
EP0180115A2 (fr) 1,2,4-Triazolyl carbamates et leurs sels d'addition acides, procédé pour leur préparation et médicaments
EP0185909A1 (fr) Composés de 5-alkyl-1-phényl-2-pipérazinoalkylpyrazolin-3-one ainsi que procédés et produits intermédiaires pour leur préparation et médicaments comprenant ces composés
DE3326724A1 (de) In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3027106C2 (fr)
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2550959C3 (de) Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP0224159B1 (fr) Composés pyridiniques substitués par des groupes basiques, leur procédé de préparation, médicaments les contenant et leur application
DD157703A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DE3043979C2 (de) N-(5-Tetrazolyl)-1-oxo-1H-thiazolo-[3,2-a]-pyrimidin-2-carboxamide
EP0094080A2 (fr) Dérivés de la pyrido(2,1-b)quinazoline
DE2714148C3 (de) 1-(Naphthylmethyl)-4-thiazolylpipirazine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE1620121A1 (de) Verfahren zur Herstellung von Pyridin- und Diazinverbindungen
DE2907536C2 (fr)
DE2651580A1 (de) Neue imidazolverbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel
AT313277B (de) Verfahren zur Herstellung neuen Triazole
DE2024350C3 (de) 1-(Benzamidoäthyl)-4-(2-pyridyl)piperazine
AT367049B (de) Verfahren zur herstellung von neuen pyrimidonderivaten
DE3300477A1 (de) Neue heterocyclische verbindungen, ihre herstellung und verwendung